Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now [Yahoo! Finance]
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at Bank of America Co. from $350.00 to $355.00. They now have a "buy" rating on the stock.
West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $390.00 price target on the stock, up previously from $350.00.
West Elects New Director to the Board